Non-parametric inference for cumulative incidence functions in competing risks studies.
about
Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort studyComplement fragment 3a priming of umbilical cord blood progenitors: safety profile.Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data.ANALYSIS OF DEPENDENTLY CENSORED DATA BASED ON QUANTILE REGRESSION.Statistical approaches to experimental design and data analysis of in vivo studies.Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.The risk of death associated with delayed coronary artery bypass surgeryCompeting risks analysis of correlated failure time data.Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survivalMarrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.Competing risk regression models for epidemiologic data.Modeling cumulative incidence function for competing risks data.FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome.Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia.Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.Practical methods for competing risks data: a review.The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemiaAllogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survivalReduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomasSuccessful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donorsReduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia.Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men.Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantationNCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrEstimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy.Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.Nonparametric multistate representations of survival and longitudinal data with measurement error.Multiple imputation methods for nonparametric inference on cumulative incidence with missing cause of failure.Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord bloodMilk intake and risk of mortality and fractures in women and men: cohort studies.Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.One-unit versus two-unit cord-blood transplantation for hematologic cancers.Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST).An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes.Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancyBone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.
P2860
Q22306543-82C1DA3E-CBF2-4879-B243-0EB6FD8DD646Q30366297-12218AA6-2AD1-489C-8EED-51D65A8F627AQ30685539-620F07C9-AB5B-4392-95EA-68F11DBB6558Q30868535-CF963BDD-F714-4749-B8C3-E407224E477EQ32111107-0CD9DADA-CD05-465F-9A3A-60065186B209Q32162246-8B9F5FD7-5449-4D98-86B5-AA01D0C84357Q33248958-69296FC6-FE6E-4FC6-B79A-6F8B704E85C9Q33293296-324728C2-C3B6-4A42-9DA0-8839AF909CB3Q33424344-DD006673-E120-4917-A5E2-91535D640A5CQ33428284-0C62BA97-1575-4FB3-8459-64FB70176F44Q33459711-A71F04DB-422A-4521-B873-50134863E812Q33510698-C9C18879-EF60-42B0-B2C5-30354F55750DQ33641201-C55D1547-9A46-4ACB-B522-84B77B1EA3CBQ33643203-F963B4B4-A078-4EF0-9061-4615D7F3A7D6Q33724796-7C21ECE0-FF2D-4BC8-A5F7-824ACCBFD2A3Q33768055-F9A51745-2CA8-4AB8-AD3A-A4A3BC64CD5CQ33781150-DB0AC834-3C58-4624-9B2F-1D6E870A742DQ33788920-BD2F8218-F365-4E2F-9272-CAAF0064A59CQ33816017-97AFE636-AA2B-496E-AD8A-E0888F036996Q33816659-F7302F31-AB4A-4280-BB02-73E7DE7C3C4CQ33850163-63150A2A-D20D-4458-BC81-010BCBE2B724Q33937048-9F41D5E7-BF3D-47AD-B138-D658CC8281DFQ33937055-3C08E8E4-01AF-44D9-9FD6-9F90F2E260FAQ33996358-2FC9A5F3-AE29-4414-8205-519589FFC9EFQ34008962-BB66FF55-C118-4B41-A336-CE1EE3814625Q34016144-FAB70575-959D-47D3-B0C5-70A8F1AFFCE1Q34033553-5554B329-5445-4EBD-8959-3B4F558E3746Q34044024-04C2E8E0-75F7-44B2-8130-774810780B2AQ34046343-D9E283AD-2199-45E1-9A9C-3C2DE139C37CQ34144161-13D890C5-CDD1-4C88-9D42-A191470BC4EDQ34246701-80742DE6-146C-4057-91E9-03F0A49DA448Q34308121-B71056FA-C243-4153-8E48-127710058FF0Q34374133-04E23ADB-873B-44E5-AF07-F1E73EDD5E10Q34417422-5709D873-1476-440D-AFAC-ABB2114C3CA7Q34553336-3F9E65A5-94B9-47F2-97BD-6FFABFD89CA7Q34637605-06C6720E-7B0A-4F17-AFB4-001A193521A5Q34649548-11B4575F-28A2-4239-AD69-B8A3233FE618Q34749373-B1FCC8C3-2DD4-42D0-8B0F-10F2DBF87386Q34749391-4A828ABC-F310-4648-BFFA-731EDB40CDBEQ34996663-BF1588C7-1173-44C2-AEAF-63A41E0282E9
P2860
Non-parametric inference for cumulative incidence functions in competing risks studies.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Non-parametric inference for cumulative incidence functions in competing risks studies.
@en
Non-parametric inference for cumulative incidence functions in competing risks studies.
@nl
type
label
Non-parametric inference for cumulative incidence functions in competing risks studies.
@en
Non-parametric inference for cumulative incidence functions in competing risks studies.
@nl
prefLabel
Non-parametric inference for cumulative incidence functions in competing risks studies.
@en
Non-parametric inference for cumulative incidence functions in competing risks studies.
@nl
P1476
Non-parametric inference for cumulative incidence functions in competing risks studies.
@en
P2093
P304
P356
10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M
P407
P577
1997-04-01T00:00:00Z